STAQ Pharma, Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Feb 10, 2025
  • 2 Class I recalls
  • No warning letters matched by name
Inspections 3 0 OAI
Recalls 6 2 Class I (33%)
Warning letters 0 None on file
510(k) clearances 0 None on file

STAQ Pharma, Inc. has 6 FDA recalls (2 Class I), 3 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "STAQ Pharma, Inc." is on file. FDA has published 2 Form 483s for STAQ Pharma, Inc..

What these totals cover: FDA records filed under the name "STAQ Pharma, Inc." and its spelling variant "Staq Pharma".

Latest recall
D-0023-2026 · Class III · Oct 9, 2025
Latest inspection
Feb 10, 2025 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls6 (2 Class I)Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections3Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

STAQ Pharma, Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

STAQ Pharma, Inc.: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 2 recall records (2 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 1 inspection (0 OAI), 0 warning letters, 3 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202510030
202400000
202300010
202200022
202110000
202010000
201900000
201800000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing STAQ Pharma, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check STAQ Pharma, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

STAQ Pharma, Inc. Form 483s

2 Form 483s published by FDA.

DateDocumentFEI
Sep 29, 2021 · Document on fda.gov 4833015144909
Sep 3, 2020 · Document on fda.gov 4833015144909

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent recalls

6 recall records from Feb 3, 2022 to Oct 9, 2025.

NumberClassProductDate
D-0023-2026Class IIIHydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ…Oct 9, 2025
D-0024-2026Class IIIKetamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc…Oct 9, 2025
D-0025-2026Class IIIFentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ…Oct 9, 2025
D-0147-2024Class IIROPivacaine HCl 0.2% PF in Sodium Chloride 1,000 mg/500 mL (2 mg per mL) Injection, 500 mL bags, Rx…Nov 29, 2023
D-0633-2022Class IHYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only…Feb 3, 2022
D-0634-2022Class IMorphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, STAQ…Feb 3, 2022

Recent FDA inspections

3 inspections from Sep 3, 2020 to Feb 10, 2025.

DateSiteProductClassificationFEI
Feb 10, 2025Denver, CODrugsVoluntary Action Indicated (VAI)3015144909
Sep 29, 2021Denver, CODrugsVoluntary Action Indicated (VAI)3015144909
Sep 3, 2020Denver, CODrugsVoluntary Action Indicated (VAI)3015144909
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3015144909Denver, CO3Feb 10, 2025

STAQ Pharma, Inc. and the FDA: common questions

Has STAQ Pharma, Inc. received an FDA warning letter?

No FDA warning letter addressed to the name "STAQ Pharma, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has STAQ Pharma, Inc. received an FDA Form 483?

FDA has published 2 Form 483s for STAQ Pharma, Inc. in its reading room, the most recent dated Sep 29, 2021. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect STAQ Pharma, Inc.?

The most recent FDA inspection on file ended Feb 10, 2025 at Denver, CO and was classified VAI. FDA has 3 inspections of STAQ Pharma, Inc. on file.

Has STAQ Pharma, Inc. had an FDA recall?

Yes. STAQ Pharma, Inc. has 6 FDA recalls on record, 2 of them Class I, the most serious class. The most recent started Oct 9, 2025.

Need more than this page shows? Ask about STAQ Pharma, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.